<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T13:07:16Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.07985" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.07985</identifier>
    <datestamp>2023-04-21T16:11:28Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2023-04-21</dc:date>
  <dc:title>GDF15 regulated by HDAC2 exerts suppressive effects on oxygen and glucose deprivation-induced pyroptosis via NLRP3/Caspase-1/ GSDMD pathway</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.07985</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Purpose:&amp;nbsp;Pyroptosis, inflammation-related programed cell death mediated by&amp;nbsp;NLRP3 inflammasome, plays a critical role in the pathogenesis of cerebral hypoxic-ischemic injury.&amp;nbsp;Our study aims to explore the biological role of growth differentiation factor (GDF)15&amp;nbsp;in&amp;nbsp;oxygen-glucose deprivation&amp;nbsp;(OGD)-induced pyroptosis. Methods: HT22 neurons were subjected to&amp;nbsp;OGD&amp;nbsp;to simulate cerebral hypoxic-ischemic injury. HT22 neurons&amp;nbsp;were transfected with plasmids to overexpress GDF15, or shRNAs constructs to silence GDF15. ELISA assay was used to detect GDF15, interleukin-1&amp;beta; (IL-1&amp;beta;), IL-18, and neuron specific enolase (NSE)&amp;nbsp;in culture medium. Cells pyroptosis was measured&amp;nbsp;by flow cytometery. Chromatin immuno-precipitation assay&amp;nbsp;was used to detect interaction of H3K27ac&amp;nbsp;with GDF15 promoter.&amp;nbsp;Results: OGD exposure caused significant increases in medium levels of IL-1, IL-18 and NSE, percentages of pyroptotic cells, and NLRP3, caspase-1, and gasdermin D (GSDMD)&amp;nbsp;protein, which were markedly reversed&amp;nbsp;by GDF15 overexpression (p-value &amp;lt; 0.001). GDF15 knockdown resulted in significant increases in medium levels of IL-1, IL-18 and NSE, percentages of pyroptotic cells, and caspase-1&amp;nbsp;and GSDMD&amp;nbsp;protein (p-value &amp;lt; 0.001). The GDF15 knockdown-induced effects were counteracted by treatment with NLRP3&amp;nbsp;inhibitor. OGD decreased H3K27ac&amp;nbsp;enrichment with promoter of GDF15&amp;nbsp;to down-regulate GDF15, but was compromised by co-treatment with HDAC2 inhibitor. Conclusion: Our data demonstrates that GDF15 attenuates OGD/R-induced pyroptosis through NLRP3/Caspase-1/GSDMD pathway. HDAC2&amp;nbsp;is involves in mediating OGD-induced&amp;nbsp;GDF15 down-regulation via H3K27ac&amp;nbsp;enrichment. GDF15 overexpression and HDAC2 inhibition&amp;nbsp;hold potential as useful therapeutic strategies&amp;nbsp;for neuroprotection.</dc:description>
  <dc:subject>GDF15; oxygen-glucose deprivation; cerebral hypoxic-ischemic injury</dc:subject>
  <dc:creator>Xiao Hua</dc:creator>
  <dc:creator>Shengtao Yao</dc:creator>
  <dc:creator>Yan Li</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>